Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot randomized controlled trial of recombinant human erythropoietin in primary progressive multiple sclerosis
2008-005125-11Phase 2Terminated
- Sponsor
- The Walton Centre
- Start
- Jan 2009
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in primary progressive multiple sclerosis (PPMS) comparing epoetin beta with placebo (2 arms). Primary endpoint: Maximum walking distance. Started Jan 2009; status: terminated.
02
Drugs
epoetin beta
03
Conditions
primary progressive multiple sclerosis (PPMS)
Beyond the preview
Go deeper on 2008-005125-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005125-11.